[EN] ADDITION SALTS OF TROMETHAMINE WITH AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORS<br/>[FR] SELS D'ADDITION DE TROMÉTHAMINE AVEC DES DÉRIVÉS D'ACIDE AZABIPHÉNYLAMINOBENZOÏQUE COMME INHIBITEURS DE DHODH
申请人:ALMIRALL SA
公开号:WO2010102825A1
公开(公告)日:2010-09-16
The present invention is directed to novel crystalline addition salts of (i) tromethamine with (ii) an azabiphenylaminobenzoic acid derivatives of formula (I) wherein R1 is selected from the group consisting of C1-C4 alkyl, C3-C4 cycloalkyl and -CF3, G1 is selected from nitrogen atoms and CH, C(CH3) and C(CF3) groups, and G2 represents a phenyl group optionally substituted with one or two substituents selected from chloro, fluoro, methoxy, ethoxy, isopropoxy, trifluoromethoxy, CF3, and -CONR7R8, wherein R7 is hydrogen and R8 is cyclopropyl or R7 and R8 together with the nitrogen atom to which they are attached form a group of formula (IA) wherein n is 1. and pharmaceutically acceptable solvates thereof.
本发明涉及一种新的晶体加合物盐,其由式(I)中的一种含有氮杂双苯基氨基苯甲酸衍生物与三甲醇胺的加合物组成,其中R1选择自C1-C4烷基,C3-C4环烷基和-CF3的群组中,G1选择自氮原子和CH,C(CH3)和C(CF3)基团,G2代表一个苯基,该苯基可选地被氯,氟,甲氧基,乙氧基,异丙氧基,三氟甲氧基,CF3和-CONR7R8中的一个或两个取代基取代,其中R7为氢,R8为环丙基或R7和R8与它们所连接的氮原子一起形成式(IA)的基团,其中n为1,以及其药学上可接受的溶剂化物。